Arlington Center for Dermatology

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Psoriasis4 trials

Phase

• Phase 34 trials

Status

• Completed2 trials
• Active, not recruiting1 trial
• Recruiting1 trial

Lead sponsor

• Janssen Research & Development, LLC3 trials
• Bristol-Myers Squibb1 trial

Running trials

• Recruiting

  Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)

  NCT07116967· Phase 3· Bristol-Myers Squibb· Source

  Contact: Angela Moore, Site 0057

• Active, not recruiting

  A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Subcutaneously Administered Guselkumab for the Treatment of Chronic Plaque Psoriasis in Pediatric Participants

  NCT03451851· Phase 3· Janssen Research & Development, LLC· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Psoriasis1 recruiting

Closed trials

• Completed

  Study of Guselkumab Versus Placebo for the Treatment of Low Body Surface Area Moderate Plaque Psoriasis

  NCT06039189· Phase 3· Janssen Research & Development, LLC· Source

• Completed

  Study of Guselkumab in Skin of Color Participants With Moderate-to-severe Plaque and/or Scalp Psoriasis

  NCT05272150· Phase 3· Janssen Research & Development, LLC· Source